# Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India

> **NCT02592057** · — · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 532 (actual)

## Conditions studied

- Hepatitis C Virus

## Interventions

- **DRUG:** SOF

## Key facts

- **NCT ID:** NCT02592057
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-30
- **Primary completion:** 2017-11-30
- **Final completion:** 2018-04-23
- **Target enrollment:** 532 (ACTUAL)
- **Last updated:** 2018-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02592057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02592057, "Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02592057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*